Company / Capital Returned to Shareholders per Share
Travere Therapeutics, Inc. Capital Returned to Shareholders per Share History
FY2016-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.06
FY2016
5-year range
-
FY2016-FY2016
Trend
-
vs FY2015
Sector context
#44 of 51
Health Care
What the data says
Travere Therapeutics, Inc.'s capital returned to shareholders per share of $0.06 is lower than 86% of companies in the Health Care sector (FY2016).
Based on SEC 10-K filings.
0.06 in FY2016.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 51This company $0.06 Sector average $2.74
▼
-97.7% below sector average
Company context
Key Data Points
- Altman Z-Score -1.15 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | $0.06 | - |
As of FY2016 · SEC 10-K · Updated Jun 30, 2026